FRESENIUS MEDICAL CARE AG Purchase Of Interests In Investments Accounted For Using Equity Method
FRESENIUS MEDICAL CARE AG (FMS) reported Purchase Of Interests In Investments Accounted For Using Equity Method of EUR 2.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Notes
ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG purchase of interests in investments accounted for using equity method for the quarter ending 2019-12-31 was -900.00K EUR.
- FRESENIUS MEDICAL CARE AG purchase of interests in investments accounted for using equity method for the quarter ending 2019-09-30 was 38.98M EUR, a 95.24% decline year-over-year.
- FRESENIUS MEDICAL CARE AG purchase of interests in investments accounted for using equity method for the quarter ending 2019-06-30 was -14.51M EUR.
- FRESENIUS MEDICAL CARE AG purchase of interests in investments accounted for using equity method for the quarter ending 2019-03-31 was -282.00K EUR.
| Period end | Purchase Of Interests In Investments Accounted For Using Equity Method 3 month | Purchase Of Interests In Investments Accounted For Using Equity Method 6 month | Purchase Of Interests In Investments Accounted For Using Equity Method 9 month | Purchase Of Interests In Investments Accounted For Using Equity Method 9 month as first filed | Purchase Of Interests In Investments Accounted For Using Equity Method 12 month | Purchase Of Interests In Investments Accounted For Using Equity Method 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | 2.00M EUR 20-F · filed 2026-02-24 | |||||
| 2024-12-31 | 14.35M EUR 20-F · filed 2026-02-24 | |||||
| 2023-12-31 | 5.69M EUR 20-F · filed 2026-02-24 | |||||
| 2022-12-31 | 23.31M EUR 20-F · filed 2025-02-25 | |||||
| 2021-12-31 | 77.01M EUR 20-F · filed 2024-02-20 | |||||
| 2020-12-31 | 10.90M EUR 20-F · filed 2023-02-22 | |||||
| 2019-12-31 | -900.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-02-22 | 38.08M EUR derived: sum of 2 quarters · filed 2022-02-22 | 23.57M EUR derived: sum of 3 quarters · filed 2022-02-22 | 23.29M EUR 20-F · filed 2022-02-22 | 34.60M EUR 20-F · filed 2020-02-20 | |
| 2019-09-30 | 38.98M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 24.47M EUR derived: sum of 2 quarters · filed 2019-10-31 | 24.19M EUR 6-K · filed 2019-10-31 | -440.34M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | -14.51M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -14.79M EUR 6-K · filed 2019-07-30 | -479.32M EUR derived: sum of 3 quarters · filed 2021-02-23 | 340.16M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | -282.00K EUR 6-K · filed 2019-05-02 | -464.81M EUR derived: sum of 2 quarters · filed 2021-02-23 | 354.67M EUR derived: sum of 3 quarters · filed 2021-02-23 | 256.53M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | -464.53M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-02-23 | 354.95M EUR derived: sum of 2 quarters · filed 2021-02-23 | 256.81M EUR derived: sum of 3 quarters · filed 2021-02-23 | 109.95M EUR 20-F · filed 2021-02-23 | -590.20M EUR 20-F · filed 2019-02-20 | |
| 2018-09-30 | 819.48M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 721.34M EUR derived: sum of 2 quarters · filed 2019-10-31 | 574.48M EUR 6-K · filed 2019-10-31 | -574.48M EUR 6-K · filed 2018-10-30 | 609.25M EUR derived: sum of 4 quarters · filed 2020-02-20 | |
| 2018-06-30 | -98.14M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -245.01M EUR 6-K · filed 2019-07-30 | -210.23M EUR derived: sum of 3 quarters · filed 2020-02-20 | -211.82M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||
| 2018-03-31 | -146.87M EUR 6-K · filed 2019-05-02 | -112.09M EUR derived: sum of 2 quarters · filed 2020-02-20 | -113.68M EUR derived: sum of 3 quarters · filed 2020-02-20 | -125.17M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||
| 2017-12-31 | 34.78M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 33.19M EUR derived: sum of 2 quarters · filed 2020-02-20 | 21.69M EUR derived: sum of 3 quarters · filed 2020-02-20 | 18.00M EUR 20-F · filed 2020-02-20 | ||
| 2017-09-30 | -1.59M EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-10-30 | -13.09M EUR derived: sum of 2 quarters · filed 2018-10-30 | -16.78M EUR 6-K · filed 2018-10-30 | |||
| 2017-06-30 | -11.50M EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-01 | -15.19M EUR 6-K · filed 2018-08-01 | ||||
| 2017-03-31 | -3.69M EUR 6-K · filed 2018-05-03 | |||||
| 2016-12-31 | -129.76M EUR 20-F · filed 2019-02-20 | 129.76M EUR 20-F · filed 2018-02-27 | ||||
| 2015-12-31 | 165.93M EUR 20-F · filed 2018-02-27 |